The sheer enormity of the people who could potentially benefit from these drugs has really led to a significant level of foot dragging among public and private payers, and its not because they dont believe that these pharmaceuticals actually work in terms of improving patient outcomes, he told Straight Arrow
due to NDMA (cancer causing carcinogen) impurities
In a press release on results of the Surmount-5 open-label randomized trial, Lilly reported: On average, Zepbound led to a superior weight loss of 20.2% compared to 13.7% with Wegovy.i At 72 weeks, Zepbound beat Wegovy on both the primary endpoint and all five key secondary endpoints in this trial of adults living with obesity or overweight with at least one weight-related medical problem and without diabetes
Common B12 supplementation forms include cyanocobalamin tablets (taken orally), methylcobalamin lozenges, and monthly or quarterly B12 injections
The cardiovascular benefits have substantial support, especially for certain clinical populations